Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 201

    1.

    Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.

    Gelisken F, Lafaut BA, Inhoffen W, Voelker M, Grisanti S, Bartz-Schmidt KU.

    Br J Ophthalmol. 2004 Feb;88(2):207-11.PMID: 14736776 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.

    Parodi MB, Da Pozzo S, Ravalico G.

    Br J Ophthalmol. 2003 Feb;87(2):177-83.PMID: 12543747 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

    Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.

    Ghazi NG, Jabbour NM, De La Cruz ZC, Green WR.

    Retina. 2001;21(5):478-86.PMID: 11642377 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

    Moshfeghi DM, Kaiser PK, Grossniklaus HE, Sternberg P Jr, Sears JE, Johnson MW, Ratliff N, Branco A, Blumenkranz MS, Lewis H.

    Am J Ophthalmol. 2003 Mar;135(3):343-50.PMID: 12614752 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sequence of early vascular events after photodynamic therapy.

    Michels S, Schmidt-Erfurth U.

    Invest Ophthalmol Vis Sci. 2003 May;44(5):2147-54.PMID: 12714655 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.

    Ladd BS, Solomon SD, Bressler NM, Bressler SB.

    Am J Ophthalmol. 2001 Nov;132(5):659-67.PMID: 11704027 [PubMed - indexed for MEDLINE]Related articles

    8.

    Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.

    Grisanti S, Tatar O, Canbek S, Lafaut BA, Gelisken F, Inhoffen W, Szurman P, Aisenbrey S, Oficjalska-Mlynczak J, Bartz-Schmidt KU.

    Am J Ophthalmol. 2004 May;137(5):914-23.PMID: 15126158 [PubMed - indexed for MEDLINE]Related articles

    9.

    Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.

    Obata R, Yanagi Y, Kami J, Takahashi H, Inoue Y, Tamaki Y.

    Jpn J Ophthalmol. 2006 Jul-Aug;50(4):354-60.PMID: 16897221 [PubMed - indexed for MEDLINE]Related articles

    10.

    Case series outcomes at 1 week following verteporfin photodynamic therapy.

    Tan W, Beaumont PE, Chang AA.

    Retina. 2003 Apr;23(2):166-70.PMID: 12707594 [PubMed - indexed for MEDLINE]Related articles

    11.

    12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.

    Retina. 2008 Feb;28(2):289-97.PMID: 18301052 [PubMed - indexed for MEDLINE]Related articles

    12.

    Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.

    Mori R, Kelkar A, De Laey JJ.

    Bull Soc Belge Ophtalmol. 2006;(299):57-64.PMID: 16681088 [PubMed - indexed for MEDLINE]Related articles

    14.

    Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

    Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration.

    Kozak I, Cheng L, Cochran DE, Freeman WR.

    Br J Ophthalmol. 2006 Sep;90(9):1152-6. Epub 2006 Jun 14.PMID: 16774958 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation]

    Gabel-Pfisterer A, Wehner A, Heimann H, Foerster MH, Wachtlin J.

    Ophthalmologe. 2005 Jun;102(6):592-6. German. PMID: 15662503 [PubMed - indexed for MEDLINE]Related articles

    18.

    Photodynamic therapy for age-related macular degeneration.

    Jin C, Ge J, Zhou S, Chen H, Zhong X, Jiang R, Chen L, Chen L.

    Yan Ke Xue Bao. 2004 Sep;20(3):158-62.PMID: 15499723 [PubMed - indexed for MEDLINE]Related articles

    19.

    Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.

    Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Lüke M, Bartz-Schmidt KU, Grisanti S.

    Am J Ophthalmol. 2006 Jul;142(1):95-104.PMID: 16815256 [PubMed - indexed for MEDLINE]Related articles

    20.

    Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.

    Haddad WM, Coscas G, Soubrane G.

    Br J Ophthalmol. 2002 Jun;86(6):663-9.PMID: 12034690 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data